Eczema: all 1,088 studies

Page 2 of 11. Open to participants first (130), then studies with results posted, then the rest; newest registration first within each.

• Finding Patterns In Clinical Trial Experiences of Patients With EczemaNot yet recruitingNCT05747378
• A Study to Assess the Long-Term Safety and Efficacy of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic DermatitisEnrolling by invitationNCT05735483Phase 3
• Pharmacodynamic Blood Characteristics of ICP-332 in Patients With Moderate to Severe Atopic DermatitisRecruitingNCT05702268Phase 2
• Study of Eblasakimab in Male or Female Moderate-to-Severe Atopic Dermatitis Patients Previously Treated With DupilumabRecruitingNCT05694884Phase 2
• A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis.RecruitingNCT05689151
• A Phase III Extended Clinical Trial of Jaktinib Hydrochloride Tablets in the Treatment of Moderate and Severe Atopic DermatitisRecruitingNCT05676242Phase 3
• Effects of Electroacupuncture to Relieve Itching Degree in Patients With Chronic Atopic EczemaNot yet recruitingNCT05529836Not applicable
• A Study of QY201 Tablet in Subjects With Moderate to Severe Atopic DermatitisNot yet recruitingNCT05525715Phase 1/2
• Vitamin D Treatment Effect for Atopic Dermatitis in ChildrenRecruitingNCT05523986Not applicable
• The Effect of Intervention and Mechanism of ICBT on Chronic Itching in Patients With Atopic DermatitisNot yet recruitingNCT05502848Not applicable
• Meditation in Inflammatory DermatosisRecruitingNCT05500794Not applicable
• Pre-approval Single-patient Expanded Access for Abrocitinib (PF-04965842)AvailableNCT05466578
• Effects of a Mixed Chinese Herbal Formula on Atopic DermatitisNot yet recruitingNCT05455060Phase 3
• Study on the Influence of Climatic and Environmental Factors on Respiratory Diseases in Sanya, Hainan Province, China.RecruitingNCT05330637
• Dupixent and Narrowband UVB for Atopic DermatitisRecruitingNCT05285839Phase 4
• SAD/MAD Safety and PK Study of RBN-3143 in Healthy and Atopic Dermatitis SubjectsRecruitingNCT05215808Phase 1
• Mother-Infant Cohort Study in Malaysia and ChinaRecruitingNCT04919265
• Long-term Follow-up Study to Evaluate the Safety and Explore the Efficacy of Multiple Doses of FURESTEM-AD InjNot yet recruitingNCT04730024
• A Prospective Sample Collection Study Using Non-invasive Methods to Investigate Biomarkers in AD PatientsRecruitingNCT04699695
• Safety, Tolerability and Efficacy of ZEP-3Na (0.1% or 1%) Compared to Placebo in Subjects With Mild to Moderate Atopic DermatitisRecruitingNCT04307862Phase 2
• Identifying Atopic Dermatitis Patients at Risk for Developing Conjunctivitis During Dupilumab TreatmentRecruitingNCT04276623
• Prospective Longitudinal Observational Research in Atopic DermatitisRecruitingNCT04240522
• TLA in Children With Moderate to Severe Atopic Eczema (TLA4AE)RecruitingNCT03795506Not applicable
• TREAT NL (TREatment of ATopic Eczema, the Netherlands) Registry: Dutch National Registry for Patients With Moderate-to-severe Atopic Eczema on Photo- or Systemic TherapiesRecruitingNCT03621137
• BioDay Registry: Data Collection Regarding the Use of New Systemic Treatment Options in Patients with Atopic DermatitisRecruitingNCT03549416
• TREATgermany: German National Clinical Registry for Patients With Moderate-to-severe Atopic DermatitisRecruitingNCT03057860
• Treatment of AD With IgE Specific Immunoadsorption (IGEIAAD)RecruitingNCT02365246Phase 2
• Effects of Treatments on Atopic DermatitisRecruitingNCT01631617Phase 2
• Studies of Skin Microbes in Healthy People and in People With Skin ConditionsRecruitingNCT00605878
• Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis ResearchRecruitingNCT00177268
• Long-Term Study (AtDvance) to Evaluate GSK1070806 in Atopic Dermatitis.TerminatedNCT06447506Phase 2Results posted
• Lebrikizumab Pen Ease of Use in Participants With Atopic DermatitisCompletedNCT06444165Phase 3Results posted
• A Study to Evaluate the Efficacy, and Safety Study of Ruxolitinib Cream in Adults With Moderate Atopic DermatitisCompletedNCT06238817Phase 3Results posted
• Phase 2a Study of Efficacy and Safety of OpSCF in Moderate to Severe AD (Atopic Dermatitis)CompletedNCT06101823Phase 2Results posted
• A Dose Finding Study to Investigate the Safety and Effectiveness of GSK1070806 in Adult Participants With Moderate to Severe Atopic DermatitisTerminatedNCT05999799Phase 2Results posted
• Effectiveness and Safety of Lebrikizumab Treatment in Adults and Adolescents With Moderate-to-Severe Atopic DermatitisCompletedNCT05990725Phase 3Results posted
• A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of IMG-007 in Adults With Atopic Dermatitis (AD)TerminatedNCT05984784Phase 1/2Results posted
• Topical Ruxolitinib Evaluation in Chronic Hand EczemaCompletedNCT05906628Phase 2Results posted
• A Study to Learn About the Study Medicine Etrasimod in Adults With Moderate to Severe Atopic Dermatitis (AD) Who Have Already Tried Treatments Taken by Mouth or by InjectionTerminatedNCT05732454Phase 2/3Results posted
• A Study Assessing Rocatinlimab in Combination With Topical Corticosteroid and/or Topical Calcineurin Inhibitors in Adult Participants With Moderate-to-severe Atopic Dermatitis (AD)CompletedNCT05724199Phase 3Results posted
• A Study to Learn How Well the Study Treatment Zabedosertib (BAY1834845) Works and How Safe it is Compared to Placebo in Adult Participants With Moderate-to-severe Atopic DermatitisCompletedNCT05656911Phase 2Results posted
• A Study Assessing Rocatinlimab (AMG 451) Monotherapy in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Horizon)CompletedNCT05651711Phase 3Results posted
• A Study to Evaluate Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Adolescent and Adult Participants With Moderate to Severe Atopic DermatitisCompletedNCT05601882Phase 3Results posted
• Safety and Efficacy Study of EVO101 Topical Cream in Atopic DermatitisCompletedNCT05579899Phase 2Results posted
• A Multi-omics Disease Signature Trial in Adult Patients With Moderate to Severe ADCompletedNCT05470114Phase 2Results posted
• Study to Assess the Efficacy and Safety of Orismilast in Atopic Dermatitis (ADESOS)CompletedNCT05469464Phase 2Results posted
• Study of Ruxolitinib Cream in Adolescents With Atopic DermatitisCompletedNCT05456529Phase 3Results posted
• A Long-Term Extension Trial in Participants With Atopic Dermatitis Who Participated in Previous EDP1815 TrialsTerminatedNCT05439941Phase 2Results posted
• A Study to Learn About The Study Medicine (PF-07038124) In Patients With Mild To Moderate Atopic Dermatitis Or Mild To Severe Plaque Psoriasis.CompletedNCT05375955Phase 2Results posted
• A Study to Learn About Abrocitinib Tablets in People With Atopic Dermatitis in IndiaCompletedNCT05375929Phase 3Results posted
• A Long-term Trial of OPA-15406 in Infants With Atopic DermatitisCompletedNCT05372653Phase 3Results posted
• A Study of (LY3650150) Lebrikizumab to Assess the Safety and Efficacy of Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis and Skin of ColorCompletedNCT05372419Phase 3Results posted
• A Study of Lebrikizumab (LY3650150) in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Previously Treated With DupilumabCompletedNCT05369403Phase 3Results posted
• Clinical Investigation on the Efficacy and Safety of Relizema Cream in Paedriatric PatientsCompletedNCT05259774Not applicableResults posted
• A 24 Week Trial to Compare the Efficacy and Safety of Delgocitinib Cream 20 mg/g Twice-daily With Alitretinoin Capsules Once-daily in Adult Participants With Severe Chronic Hand EczemaCompletedNCT05259722Phase 3Results posted
• Study the Safety and Efficacy of DBI-001 Gel Versus Aqueous GelTerminatedNCT05253755Phase 2Results posted
• Improvement In Scratch Behavior And Sleep In Patients With Atopic DermatitisTerminatedNCT05200403Phase 4Results posted
• Efficacy and Safety of Tralokinumab Administered by an Autoinjector in Adults and Adolescents With Moderate to Severe Atopic Dermatitis (INJECZTRA)CompletedNCT05194540Phase 3Results posted
• Maximal Use Study of Tapinarof Cream, 1% in Pediatric Subjects With Extensive Atopic DermatitisCompletedNCT05186805Phase 2Results posted
• Targeted Investigation of Microbiome EliminationTerminatedNCT05177328Phase 1Results posted
• A Study to Assess Subcutaneous Lirentelimab (AK002) in Atopic DermatitisTerminatedNCT05155085Phase 2Results posted
• Long Term Extension Study of Tapinarof Cream, 1% for Subjects With Atopic DermatitisCompletedNCT05142774Phase 3Results posted
• Study Testing Response Effect of KY1005 Against Moderate-to-Severe Atopic Dermatitis, The STREAM-AD StudyCompletedNCT05131477Phase 2Results posted
• Ruxolitinib Cream in Participants With Facial and/or Neck Atopic Dermatitis InvolvementCompletedNCT05127421Phase 2Results posted
• A Study Investigating the Effect of EDP1815 in the Treatment of Mild, Moderate and Severe Atopic DermatitisCompletedNCT05121480Phase 2Results posted
• Efficacy and Safety of LEO 152020 Tablets for the Treatment of Adults With Moderate to Severe Atopic DermatitisCompletedNCT05117060Phase 2Results posted
• Tapinarof for the Treatment of Atopic Dermatitis in Children and Adults (DMVT-505-3102)CompletedNCT05032859Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of CBP-201 in Moderate to Severe Atopic Dermatitis in ChinaCompletedNCT05017480Phase 2Results posted
• Tapinarof for the Treatment of Atopic Dermatitis in Children and AdultsCompletedNCT05014568Phase 3Results posted
• A Study of BMS-986166 or Branebrutinib for the Treatment of Participants With Atopic DermatitisCompletedNCT05014438Phase 2Results posted
• The Incidence of Venous Thromboembolism in Atopic DermatitisCompletedNCT04969653Results posted
• Open-label Multi-site Extension Trial in Subjects Who Completed the DELTA 1 or DELTA 2 TrialsCompletedNCT04949841Phase 3Results posted
• An Evaluation of LEO 138559 in Adults With Moderate to Severe Atopic Dermatitis.CompletedNCT04922021Phase 2Results posted
• A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children With Atopic Dermatitis (TRuE-AD3)CompletedNCT04921969Phase 3Results posted
• Efficacy and Safety of Delgocitinib Cream in Adults With Moderate to Severe Chronic Hand Eczema (DELTA 2)CompletedNCT04872101Phase 3Results posted
• Efficacy and Safety of Delgocitinib Cream in Adults With Moderate to Severe Chronic Hand EczemaCompletedNCT04871711Phase 3Results posted
• The Purpose of the Study is to Evaluate the Effect of Ruxolitinib Cream on Itch in Participants With Atopic DermatitisCompletedNCT04839380Phase 2Results posted
• A Study to Assess the Efficacy and Safety of CMK389 in Patients With Moderate to Severe Atopic Dermatitis.CompletedNCT04836858Phase 2Results posted
• BROadband vs Narrowband photoTherapy for Eczema Trial Nested in the CACTI CohortTerminatedNCT04818138Not applicableResults posted
• A Study to Evaluate Safety and Effectiveness of Cendakimab (CC-93538) in Participants With Moderate to Severe Atopic DermatitisCompletedNCT04800315Phase 2Results posted
• Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis (INTEGUMENT-II)CompletedNCT04773600Phase 3Results posted
• Study of TER-101 Topical Ointment in Subjects With Atopic DermatitisCompletedNCT04753034Phase 2Results posted
• Study to Evaluate Safety and Tolerability of PF-07242813 in Healthy Participants and Participants With Atopic DermatitisCompletedNCT04668066Phase 1Results posted
• Study To Assess Efficacy, Safety, Tolerability And Pharmacokinetics Of PF-07038124 Ointment In Participants With Atopic Dermatitis Or Plaque PsoriasisCompletedNCT04664153Phase 2Results posted
• A Study of Lebrikizumab (LY3650150) on Vaccine Response in Adults With Atopic Dermatitis (ADopt-VA)CompletedNCT04626297Phase 3Results posted
• Efficacy and Safety Study of the Use of Benralizumab for Patients With Moderate to Severe Atopic DermatitisTerminatedNCT04605094Phase 2Results posted
• Study of ATI-1777 in Adult Patients With Moderate or Severe Atopic DermatitisCompletedNCT04598269Phase 2Results posted
• Tralokinumab in Combination With Topical Corticosteroids in Japanese Subjects With Moderate-to-severe Atopic DermatitisCompletedNCT04587453Phase 3Results posted
• A Study to Assess the Effects of Nemolizumab on Cytochrome P450 Substrates in Participants With Moderate-to-Severe Atopic DermatitisCompletedNCT04562116Phase 2Results posted
• A Study of the Long-Term Safety of Crisaborole Ointment, 2% in Japanese Pediatric and Adult Participants With Mild to Moderate Atopic DermatitisTerminatedNCT04498403Phase 3Results posted
• B244 Topical Spray for the Treatment of Pruritus in Adults With a History of Atopic DermatitisCompletedNCT04490109Phase 2Results posted
• A Study to Assess the Efficacy and Safety of CBP-201 in Adult Subjects With Moderate to Severe Atopic DermatitisCompletedNCT04444752Phase 2Results posted
• Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin)CompletedNCT04392154Phase 3Results posted
• Safety and Efficacy of ARQ-252 Cream in Subjects With Chronic Hand EczemaCompletedNCT04378569Phase 1/2Results posted
• A Study to Assess Immunization Responses in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Treated With NemolizumabCompletedNCT04365387Phase 2Results posted
• Crisaborole for Chinese and Japanese Subjects (≥2 Years of Age) With Mild to Moderate Atopic DermatitisCompletedNCT04360187Phase 3Results posted
• Study of Abrocitinib Compared With Dupilumab in Adults With Moderate to Severe Atopic Dermatitis on Background Topical TherapyCompletedNCT04345367Phase 3Results posted
• Topically Applied AMTX-100 CF for Adult Patients With Mild to Moderate Atopic DermatitisCompletedNCT04313400Phase 1/2Results posted
• Apremilast 30 mg Twice Daily (BID) Combined With DupilumabCompletedNCT04306965Phase 2Results posted
• Study to Assess the Safety and Efficacy of Lebrikizumab (LY3650150) in Adolescent Participants With Moderate-to-Severe Atopic DermatitisCompletedNCT04250350Phase 3Results posted

← Eczema overview